L-733,060 hydrochloride is a potent tachykinin NK1 receptor antagonist; it inhibits neurogenic plasma extravasation at doses that do not cause adverse cardiovascular effects in rodents; it exhibits antitumor activity by inducing concentration-dependent cytotoxicity in COLO858 cells, inhibiting proliferation of MELH0 cells (IC50: 27.5 μM at 24 h and 18.9 μM at 48 h), and suppressing growth of COLO679 cells (IC50: 33.8 μM at 30 h and 31.5 μM at 72 h); it also significantly inhibits electrically stimulated plasma extravasation in the dura mater of rats in vivo (ID50: 212 ± 19 μg/kg, i.v.).